#Hip Replacement Implant Market 2019

[industrynewsupdates]

Bioresorbable Polymers Market Growth: Key Drivers and Trends to Watch

The global bioresorbable polymers market was valued at USD 1.30 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 13.8% from 2023 to 2030. The market expansion is primarily driven by a combination of factors, including the rising consumer health awareness, improvements in healthcare facilities, and an increasing number of surgical procedures performed worldwide. According to data from the National Library of Medicine (NLM), around 310 million major surgeries are conducted globally each year, with 20 million surgeries taking place in Europe and 40 to 50 million in the United States. Bioresorbable polymers are a class of materials that can be naturally broken down and absorbed by the body over time, making them highly suitable for medical applications.

These polymers are produced by polymerizing bio-based raw materials through specialized industrial processes. The increasing demand for medical implants, such as cochlear implants, pacemakers, breast implants, and hip implants, is another significant factor driving the growth of the bioresorbable polymers market. As reported by the National Institute on Deafness and Other Communication Disorders (NIDCD), over 737,000 cochlear implants were implanted globally by December 2019. Similarly, the Organization for Economic Cooperation and Development (OECD) noted that hip replacement surgeries increased by 22% between 2009 and 2019, and knee replacements saw an increase of 35% in the same period. This growing need for medical implants is further boosting the market demand for bioresorbable polymers.

Gather more insights about the market drivers, restrains and growth of the Bioresorbable Polymers Market

Application Insights

In 2022, the orthopedics segment emerged as the leading application for bioresorbable polymers, accounting for 43.6% of the total market revenue. This dominance is largely driven by the increasing prevalence of orthopedic conditions such as arthritis, osteoporosis, and degenerative joint diseases, which are exacerbated by factors like an aging population, sedentary lifestyles, obesity, and a lack of physical activity. The rising demand for orthopedic procedures, including knee and hip replacements, is expected to continue fueling growth in this segment.

For example, the National Institutes of Health (NIH) reported that total knee arthroplasty (TKA) was the most commonly performed inpatient surgical procedure in the U.S., with over 1.37 million procedures performed in 2020. The number of TKA surgeries is expected to rise significantly, reaching 3.48 million annually by 2030. Medical products such as screws, sutures, stents, and pins made from bioresorbable polymers are increasingly being used in a variety of medical procedures, including joint repairs and prosthetics. Companies like Evonik Industries AG are developing and offering a range of bioresorbable medical products, such as surgical screws, which are designed to enhance patient care by improving clinical outcomes and reducing the need for additional surgeries. These resorbable implants also help to lower healthcare costs by eliminating the need for secondary removal procedures, a key benefit that is driving their adoption.

Another promising application area for bioresorbable polymers is drug delivery, which is projected to experience the fastest growth during the forecast period, with a CAGR of 15.7%. This growth is largely attributed to the rising prevalence of chronic diseases and the expanding aging population, both of which create a growing demand for more efficient drug delivery systems. Bioresorbable polymers are especially beneficial in drug delivery because they reduce the need for invasive procedures. For instance, implantable devices or sustained-release formulations can help minimize the frequency of invasive procedures, leading to improved patient comfort, reduced healthcare costs, and better therapeutic outcomes.

A notable development in this area occurred in June 2020, when Evonik launched the RESOMER Precise platform, a breakthrough innovation in custom functional polymeric excipients. This platform allows pharmaceutical companies to have unprecedented control over the release profile of parenteral drug products, which is crucial for ensuring consistent and effective treatment. The RESOMER platform, developed using Evonik’s advanced process technology, not only improves the stability of drug products but also helps to mitigate regulatory risks associated with complex drug formulations. This innovation is expected to contribute significantly to the growth of bioresorbable polymers in drug delivery applications, offering enhanced precision and effectiveness in treating a variety of medical conditions.

Order a free sample PDF of the Bioresorbable Polymers Market Intelligence Study, published by Grand View Research.

[adityarana1687-blog]

Lower Extremity Implants Market To Reach $16.25 Billion By 2030

The global lower extremity implants market size is anticipated to reach USD 16.25 billion by 2030 and projected to grow at a CAGR of 2.96% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of robotic assisted surgeries is anticipated to boost market growth. In June 2024, Meril, a medical devices company based in Gujarat, launched a surgical robotic technology called MISSO. MISSO will offer real-time support to surgeons during knee replacement procedures. The incorporation of AI in this system has enabled an 83% reduction in pre-operative planning time and has led to enhanced customization.

Increasing participation in sports across the globe is boosting market growth. According to the Aspen Institute report, the rate of sports engagement among Asian children aged 6 to 12 rose to 42% in 2022, an increase from 35% in 2019 prior to the pandemic. Similarly, according to the SGB Media article, the overall participation rate of teams in the U.S. (6 years and older) increased by 3.7% to reach 70.8 million, which matches the level seen in 2019 before the pandemic and represents the highest number of people participating in team sports in the past ten years. As participation in sports and recreational activities grows globally, there is a corresponding rise in sports-related injuries, particularly involving the lower extremities. For instance, the annual injury incidence rate averaged 5.40 injuries per 100,000 participants. Men experienced a higher incidence rate at 6.44 per 100,000 compared to women at 3.34 per 100,000. Sporting activities had an incidence rate of 9.88 per 100,000, which was higher than cycling at 2.81 per 100,000, fitness at 0.21 per 100,000, or walking at 0.03 per 100,000.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. Furthermore, increasing knee replacement surgeries are fostering market growth. For instance, the Agency for Healthcare Research and Quality reports that over 600,000 knee replacement surgeries are carried out annually in the U.S. In addition, the increasing funding from government and non-government bodies to develop advanced product is driving market growth. For instance, in June 2022, Towfighian was awarded a USD 2.3 million grant from the National Institutes of Health (NIH) for conducting research on smart knee replacements.

The expansion of health insurance coverage in various regions, including coverage for orthopedic procedures, makes these surgeries more accessible to a broader population. Moreover, rising incidence of chronic diseases such as rheumatoid arthritis are escalating market growth. According  to the 2023 World Obesity Atlas report, more than half of the global population is projected to be overweight or obese by 2035 without significant intervention. In addition, the study published in NIH in 2023 found that obese women experience higher rates of specific types of fractures, such as thigh and ankle fractures, and lower rates of hip and wrist fractures, compared to postmenopausal women of normal weight.

Request a free sample copy or view report summary: Lower Extremity Implants Market Report

Lower Extremity Implants Market Report Highlights

Based on type, the foot & ankle segment led the market with the largest revenue share of 48.88% in 2023, owing to the increasing incidence of foot and ankle fractures

Based on biomaterial, the natural biomaterials segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the rising preference for biocompatible and bioresorbable materials

Based on end use, the ASCs segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the increasing number of ASCs across the globe

North America dominated the market with the revenue share of 48.8% in 2023, due to the presence of key market players. Furthermore, increasing prevalence of chronic diseases will supplement market growth.

Lower Extremity Implants Market Segmentation

Grand View Research has segmented the global lower extremity implants market report based on type, biomaterial, end-use, and region:

Lower Extremity Implants Type Outlook (Revenue, USD Million, 2018 - 2030)

Knee

Hip

Foot & Ankle

Lower Extremity Implants Biomaterial Outlook (Revenue, USD Million, 2018 - 2030)

Metallic Biomaterials

Ceramic Biomaterials

Polymeric Biomaterials

Natural Biomaterials

Lower Extremity Implants End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

ASCs

Clinics

Lower Extremity Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in the Lower Extremity Implants Market

Stryker

Johnson & Johnson (DePuy Synthes)

Zimmer Biomet

Smith + Nephew

Össur

DJO Global

Acumed, LLC

Arthrex, Inc.

CONMED

Orthofix

[healthcaremarketfmi]

Cartilage Repair Market is Expected to Generate Huge Profits by 2032

The global cartilage repair market is expected to reach a value of US$ 3.9 Bn by 2032, with the market growing at a stellar CAGR of 13.9% from 2022 to 2032. Scaling up from a value of US$ 1.60 Bn in 2021, the target market is set to reach an estimated US$ 1 Bn in 2022. The rising cases of osteoarthritis are fueling the demand for the cartilage repair market during the forecast period.

In the recent past, cases of osteoarthritis have become more prevalent all over the world. As per a report by the University of North Carolina, around one million knee and hip replacement operations are conducted annually in the United States. In the U.S., osteoarthritis cases are accountable for a financial burden of $136.8 Bn per year. A study published by the Arthritis Foundation in 2019 estimated that degenerative joint diseases like osteoarthritis will impact more than 130 million people by 2050.

Again, it is expected that the growing cases of osteoarthritis will propel the demand for cartilage repair and regeneration products. The most frequently used treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. All of this positively influence the market for cartilage repair. Additionally, as opposed to total knee replacement surgeries, cartilage repair surgeries deliver better and longer-lasting results than other surgeries.

Furthermore, in the past few years, more and more companies are focusing on the development of cartilage regeneration products. This is because governments across the globe are increasing investments in regenerative medicine for cartilage regeneration research. There has also been a surge in clinical trials and the development of new treatments for cartilage regeneration. Besides, the development of a strong pipeline of products based on various methods of cartilage repair available in the market owing to considerable investments in R&D by key market players will further propel the target market growth during the forecast period.

“Increasing osteoarthritis cases coupled with rising demand for treatment will further supplement the global growth of the cartilage repair market over the forecast period,” says an FMI analyst.

Key Takeaways:

The high costs of these procedures are expected to restrict the growth of the cartilage repair market.

By treatment modalities, the cell-based segment will continue to dominate the global marketplace.

On the basis of end-user, the hospital segment will account for the largest market share.

The cartilage repair market in the United States will grow at a CAGR of 13.7% during 2022-2032.

China’s cartilage repair market will register a CAGR of 13.2% during the assessment period.

Competitive Landscape 

DePuy Synthes, Smith & Nephew plc, Zimmer Biomet, CONMED Corporation, and Stryker Corporation among others are some of the major players in the cartilage repair market profiled in the full version of the report.

Key market participants are focusing on utilizing various organic and inorganic strategies. These firms are investing in research and development activities, introducing new products, and upgrading current ones. Inorganic tactics like mergers, acquisitions, and partnerships are also employed by these businesses.

For More Information : https://www.futuremarketinsights.com/reports/cartilage-repair-market

More Insights into Cartilage Repair Market Report

In its latest report, FMI offers an unbiased analysis of the global cartilage repair market, providing historical data from 2015 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of application (hyaline cartilage, fibrocartilage), site (knee, hip, ankle and foot, other application sites), end user (hospitals, ambulatory surgery centers and clinics), and region.

According to the latest FMI reports, based on segmentation, the knee segment is expected to dominate the global marketplace. This segment will contribute considerably to the overall market revenue. This is due to a surge in arthroscopy procedures. In terms of end-user, the hospital segment will lead the global market growth.

Based on region, the cartilage repair market in the United States will present impressive growth over 2022-2032. The target market in this country will register a CAGR of 13.7%. Owing to the rising incidences of bone and joint disorders along with a growing geriatric population pushes the growth of the cartilage repair market in the U.S. In addition, South Korea, China, Japan, and United Kingdom are some of the other countries that demonstrate impressive growth during the forecast period.

Key segments

By Application:

Hyaline Cartilage

Fibrocartilage

By Site:

Knee

Hip

Ankle and Foot

Other Application Sites

By End-User:

Hospitals

Ambulatory Surgery Centres and Clinics

[pearlsmith25]

Nanoceramic Powder Market Report Explored in Latest Research Forecast Period 2022-2030

Nanoceramic powder refers to a type of ceramic material that is composed of tiny particles that are typically less than 100 nanometers in size. These powders are typically made using advanced manufacturing processes such as chemical vapor deposition, sol-gel synthesis, or high-energy ball milling. Nanoceramic powders are highly sought after for their unique properties, such as high strength, hardness, and resistance to wear and corrosion. They are used in a wide range of applications, including coatings, composites, electronics, and energy storage.

One of the key advantages of nanoceramic powders is their large surface area to volume ratio, which can enhance their reactivity and catalytic properties. They also have a high degree of homogeneity, which can improve their mechanical and thermal properties. However, the production of nanoceramic powders can be complex and expensive due to the advanced manufacturing techniques required. Additionally, the potential health and environmental risks associated with the production and handling of nanoparticles are a concern, and appropriate safety measures must be taken to minimize these risks.

The global nanoceramic powder market is expected to grow significantly in the coming years. This growth can be attributed to the increasing demand for nanoceramic powders in a wide range of applications, including automotive, aerospace, electronics, energy, and biomedical industries.

The automotive and aerospace industries, in particular, are expected to drive the growth of the nanoceramic powder market. Nanoceramic coatings can be used to improve the performance and durability of engine components and aircraft parts, leading to improved fuel efficiency and reduced maintenance costs.

The electronics industry is also a significant market for nanoceramic powders, as they can be used in the production of advanced electronic devices such as sensors, capacitors, and batteries. Nanoceramic powders are also used in the production of high-performance ceramics for applications such as cutting tools and bearings.

Geographically, the Asia-Pacific region is expected to be the largest market for nanoceramic powders due to the increasing demand from the automotive and electronics industries in countries such as China, Japan, and South Korea.

The global nanoceramic powder market size is expected to witness potential gains in the future and register a significant CAGR of 18% over the forecast period (2019 - 2027).

Major players operating in the gloabal nanoceramic powder market include, Innovnano, Synkera Technologies, Inc., and Nitto Denko Corporation

The automotive industry is expected to be a major driver of growth in the nanoceramic powder market. Nanoceramic coatings can improve the performance and durability of engine components, leading to improved fuel efficiency and reduced maintenance costs. In addition, nanoceramic coatings can enhance the aesthetics of automotive components, such as wheels and trim.

The electronics industry is also expected to drive growth in the nanoceramic powder market. Nanoceramic powders can be used in the production of high-performance electronic components, such as capacitors, sensors, and batteries. In addition, the increasing demand for smartphones, tablets, and other electronic devices is expected to boost the demand for nanoceramic powders.

The medical and healthcare industries are also expected to drive growth in the nanoceramic powder market. Nanoceramic powders can be used in the production of medical implants, such as dental implants and hip replacements. Nanoceramic coatings can also be used to improve the biocompatibility of medical devices.

The demand for nanoceramic powders is increasing rapidly in various industries, which is driving the growth of the nanoceramic powder market. The demand for nanoceramic powders is being driven by their unique properties, such as high strength, hardness, and resistance to wear and corrosion, which make them suitable for use in a wide range of applications.

One of the key factors driving the demand for nanoceramic powders is the increasing demand from the automotive industry. Nanoceramic coatings can be used to improve the performance and durability of engine components, leading to improved fuel efficiency and reduced maintenance costs. In addition, nanoceramic coatings can enhance the aesthetics of automotive components, such as wheels and trim.

The electronics industry is also driving the demand for nanoceramic powders. Nanoceramic powders can be used in the production of high-performance electronic components, such as capacitors, sensors, and batteries. The increasing demand for smartphones, tablets, and other electronic devices is also boosting the demand for nanoceramic powders.

The medical and healthcare industries are also driving the demand for nanoceramic powders. Nanoceramic powders can be used in the production of medical implants, such as dental implants and hip replacements. Nanoceramic coatings can also be used to improve the biocompatibility of medical devices.

In addition, the demand for nanoceramic powders is being driven by their use in the production of high-performance ceramics for applications such as cutting tools and bearings.

Nanoceramic powders have a wide range of applications in various industries. Some of the key applications of nanoceramic powders are:

Automotive Industry: Nanoceramic powders can be used to produce high-performance coatings for engine components, such as pistons, valves, and bearings. These coatings provide improved wear resistance and can help to increase fuel efficiency.

Electronics Industry: Nanoceramic powders are used in the production of advanced electronic components such as capacitors, sensors, and batteries. These powders can help to improve the performance and efficiency of these components.

Biomedical Industry: Nanoceramic powders can be used to produce medical implants such as dental implants, hip replacements, and bone screws. These powders are biocompatible and can improve the integration of the implant with the surrounding tissue.

Energy Industry: Nanoceramic powders can be used to produce high-performance materials for energy storage and conversion, such as fuel cells and batteries. These powders can help to improve the efficiency and performance of these devices.

Aerospace Industry: Nanoceramic powders can be used to produce coatings for aircraft components such as engines, landing gear, and structural parts. These coatings can help to improve the durability and reduce the weight of these components.

Textile Industry: Nanoceramic powders can be used to produce textiles with enhanced properties such as flame resistance, UV resistance, and antibacterial properties.

The use of nanoceramic powders in various industries offers several benefits. Some of the key benefits of using nanoceramic powders are:

Improved Performance: Nanoceramic powders offer improved performance characteristics, such as higher strength, hardness, and wear resistance, compared to traditional materials. This makes them suitable for use in high-performance applications where durability and performance are critical.

Increased Efficiency: The use of nanoceramic coatings can help to increase the efficiency of various components, such as engines, by reducing friction and improving heat transfer. This can lead to improved fuel efficiency and reduced maintenance costs.

Enhanced Aesthetics: Nanoceramic coatings can also enhance the aesthetics of various components, such as automotive parts, by providing a smooth, uniform finish and improving the color and gloss of the surface.

Biocompatibility: Nanoceramic powders are biocompatible and can be used in the production of medical implants without causing adverse reactions in the body. This makes them ideal for use in various medical and healthcare applications.

Environmental Benefits: Nanoceramic coatings can also offer environmental benefits, such as reducing the use of harmful chemicals in the production process and extending the life of components, which reduces the need for frequent replacements.

Cost Savings: The use of nanoceramic powders can help to reduce maintenance costs and extend the lifespan of components, which can result in significant cost savings over time.

Overall, the use of nanoceramic powders offers several benefits in terms of improved performance, increased efficiency, enhanced aesthetics, biocompatibility, environmental benefits, and cost savings. The increasing demand for high-performance materials is expected to continue to drive the growth of the nanoceramic powder market in the coming years.

[super-brandessence1]

Hip Replacement Implant Market 2019 Industry Analysis, Trends and Forecast to 2025

Brandessence Market Research is working on a new report title “Hip Replacement Implant Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025.  Rising geriatric population and increasing incidences of bone related disorders are key drivers for Global Hip Replacement Implant Market.

 Scope of Global Hip Replacement Implant Market Reports –

Hip replacement also called as arthroplasty, is a surgical procedure in which parts of hip joint are removed and replaced with new implants due to various sbone disorders such as osteoarthritis, rheumatoid arthritis, joint pain, avascular necrosis, injuries and even bone tumors. The number of hip replacement procedures performed worldwide, has increased significantly and nowadays the procedure has become more common in younger people too. So, during the study of Global Hip Replacement Implant Market, we have considered Hip Replacement Implant to analyze the market.

 Get Full Report Overview @ https://www.brandessenceresearch.com/healthcare/hip-replacement-implant-market/

 Global hip replacement implant market report is segmented on the basis of product, material, end user type and regional & country level. Based on product type global hip replacement implant market is classified as total hip replacement implant, partial hip replacement implant, resurfacing implant and revision hip replacement implant. On the basis of material the global hip replacement implant market is classified as metal-on-metal, metal-on-polyethylene, ceramic-on-metal, ceramic-on-polyethylene and ceramic-on-ceramic. Based upon end user type global hip replacement implant market is segmented into hospitals, orthopedic clinics, surgical centers and others.

The regions covered in this hip replacement implant market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Hip Replacement Implant is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Hip Replacement Implant Market Reports-

Global Hip Replacement Implant Market report covers prominent players like MicroPort Scientific Corporation, Stryker Corporation, Exactech Inc., B. Braun Melsungen AG, OMNIlife Science Inc., DJO Global Inc., Zimmer Biomet, Depuy Synthes, Smith and Nephew, Corin, Waldemer Link GmbH & Co. KG, Wright Medical N.V., Arthrex, Inc, ConforMIS, Corentec, Elite Surgical Supplies (PTY) Ltd, Euros France, Evolutis, FH Orthopedics, Integra LifeSciences, Lima Corporate, Medacta, Ortosintese, Peter Brehm, Shanghai MicroPort Orthopedics, Surgival, Synergie Ingénierie Médicale, Tecomet, DJO Global and others.

Global Hip Replacement Implant Market Dynamics –

Rising geriatric population, affordable replacement procedure, rising incidences of bone disorders such as arthritis, osteoarthritis, rheumatoid arthritis, avascular necrosis and even bone tumors are major drivers for the growth of the global hip replacements implant market. Other factors such as technological advancements prevalence of obesity, increasing per capita income, increasing expenditure and accessibility on healthcare are the major key drivers for the growth of the global hip replacement implant market. The significant rise in hip surgeries is also due to the remarkable advancements in the development of minimally invasive surgeries that use techniques such as 3D printing for achieving accurate results. However, stringent FDA regulations for all metal hip implant products and substantial cost of surgeries are the major restrain the growth of the global hip replacement implant market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.

Global Hip Replacement Implant Market Regional Analysis –

North America dominates the market with highest market share due to increasing geriatric population, higher per capita income, rising incidences of osteoporosis and arthritis. According to American Joint Replacement Registry, Hip and knee implants account for more than 85% of the joint reconstruction and replacement market. More than 7 million Americans have had a knee or hip replacement surgery. An estimated 2.5 million Americans have undergone total hip arthroplasty and are living with implants.

Europe is the second largest market for hip replacement implant due to increasing incidences of bone disorders, improving healthcare infrastructure, governmental initiatives for supporting medical innovation, and awareness programs. According to National Health Services figures, the number of hip replacement operations on people aged less than 60 years has risen by 76% in the last decade, for England. There are 24 arthoplasty registries in Europe, most of national coverage and around 3.1 million hip knee arthroplasties are registered since 1975.

Asia Pacific Global Hip Replacement Implant Market is witnessed with strong growth rate majorly due high prevalence of bone related disorders, increasing population, improving healthcare facilities, rising awareness and rise in government initiatives to promote public healthcare. According to latest study related to cases of hip fractures from osteoporosis in nine Asian jurisdictions, predicted that by 2050 cases in Malaysia would be 3.55 times that of current levels, while in Singapore, the figure is 3.53 times. Researchers predicted that the total number of new hip fracture cases across all nine areas in the study would increase to 2.56 million in 2050, from 1.12 million this year.

Key Benefits for Global Hip Replacement Implant Market Reports –

Global Hip Replacement Implant     Market report covers in depth historical and forecast analysis.

Global Hip Replacement Implant     Market research report provides detail information about Market     Introduction, Market Summary, Global market Revenue (Revenue USD), Market     Drivers, Market Restraints, Market opportunities, Competitive Analysis,     Regional and Country Level.

Global Hip Replacement Implant     Market report helps to identify opportunities in market place.

Global Hip Replacement Implant     Market report covers extensive analysis of emerging trends and competitive     landscape.

Hip Replacement Implant Market Segmentation –

By Product

Total Hip Replacement Implant

Cement

Cement less

Partial Hip Replacement     Implant

Resurfacing Implant

Revision Hip Replacement     Implant

By Material 

Metal-on-Metal

Metal-on-Polyethylene

Ceramic-on-Metal

Ceramic-on-Polyethylene

Ceramic-on-Ceramic

By End User

Hospitals

Orthopedic Clinics

Surgical Centers

Others

By Region

 U.S.

 Mexico

 Canada

 UK

 France

 Germany

 Italy

 China

 Japan

 India

 Southeast Asia

 Brazil

 GCC

 Africa

 Rest of Middle East and      Africa

Hip Replacement Implant Market Key Players

MicroPort Scientific     Corporation

Stryker Corporation

Exactech Inc.

Braun Melsungen AG

OMNIlife Science Inc.

DJO Global Inc.

Zimmer Biomet

Depuy Synthes

Smith and Nephew

Corin

For more information or any query mail at sales@brandessenceresearch.com

 About us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

 Contact us:

Alan Ruffalo Business Development Manager Kemp House, 152 – 160 City Road, London EC1V 2NX Tel: +44-2038074155 / +91-7447409162 Email:alan@brandessenceresearch.com Website:www.brandessenceresearch.biz

[pranalipawarshinde]

Orthopedic Devices Market Analysis Report to 2027

Orthopedic Devices Market: Overview

Because of the growing senior population and the demand for orthopaedic devices that are capable of enhancing their quality of life, the orthopaedic device manufacturing sector is expected to develop substantially in the future years to come. Demands in the global orthopaedic devices market is expected to rise as a result of the rise in elderly population along with increased awareness about their advantages.

With the ageing of baby boomer generation and the rise in the number of obese and overweight people, the need for orthopaedic devices is likely to grow rapidly. In addition to that, increased prevalence of degenerative bone disease and growing elderly population is likely to augur well for the global orthopaedic devices market in the years to come.

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1781

Obesity and inactive lifestyles are the two primary factors projected to drive demand for orthopaedic devices. As a result, joint replacement procedures, such as hip or knee replacements, have gradually grown and are expected to continue to rise amongst those aged 65 years and over.

Hospitals are upgrading their equipment as more people become increasingly aware about the availability of modern medical as well as various orthopaedic devices. The acceptance of orthopaedic and other operations has also been aided by reimbursement for treatment expenses. These characteristics enable hospitals and clinicians to seek out more modern, higher-priced gadgets, increasing manufacturers' overall income.

Globus Medical, Inc., Zimmer Biomet Holdings, Inc., Stryker Corporation, Aesculap Implant Systems, LLC, DePuy Synthes, and Smith & Nephew plc are some of the companies in the global orthopedic devices market.In 2018, the global orthopaedic devices market was worth around US$ 46.1 Bn, and it is expected to grow at a rate of 4.3% CAGR over the forecast period, from 2019 to 2027.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=1781

Presence of Advanced Healthcare Infrastructure and Favorable Reimbursement Policies to Drive North America Market

The existence of highly advanced infrastructure, reimbursement coverage, and industry heavyweights are just a few of the reasons fueling regional growth. The number of orthopaedic procedures in the North America region is increasing due to an older target patient population and an increase in vehicle accidents.

In the US, the high frequency of orthopaedic diseases along with the increased uptake of sophisticated treatment techniques is expected to drive growth of the orthopaedic devices market in the North America region.

In addition, Asia Pacific is predicted to exhibit high growth rate over the forecast period, from 2019 to 2027. The majority of the elderly population pool is projected to be present in India and China.

As a result, in the not-too-distant future, the demand from these nations is projected to skyrocket. Furthermore, the expanding medical tourism sector is projected to attract the target patient group due to the availability of sophisticated healthcare treatments at low costs. In comparison to other nations in the regions, Japan has a significant number of implant producers and a high spending on the healthcare sector. In addition to that, rapid adoption of new technologies is likely to boost development of the market in Asia Pacific.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1781

Rise in Ageing Population and Change in Lifestyle of People to Spell Growth for the Market

During the forecast period, from 2019 to 2027, a rise in the proportion of obese and elderly people is expected to drive up the adoption rate of orthopaedic devices. Because of the changes in lifestyle, ageing population, and obesity, there has been an increased prevalence of juvenile arthritis, fibromyalgia, rheumatoid arthritis, osteoarthritis, and various other orthopaedic illnesses is on the rise.

In the last few years, the number of people injured in driving, sports, and various other activities has skyrocketed. These factors are likely to foster growth of the global orthopaedic devices market in the years to come.

To attract more consumers, a large number of global manufacturers with technological knowledge and core competencies are always working to develop and produce innovative orthopaedic products.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1781                

The development of variable axis screw systems, 3D bioprinting and tissue engineering, computer-aided implant fixation, custom-made implants, navigation technology, and minimally invasive surgery (MIS) have all seen significant acceptance rates. Many big manufacturers are working and collaborating with new market entrants with new, innovative products in the pipelines.

The information shared in this review is based on a TMR report, bearing the title, “Orthopedic Devices Market (Product - Joint Reconstruction, Spinal Devices, Trauma Fixation, Orthopedic Prosthetics, Arthroscopy Devices, Orthopedic Braces and Supports, Orthopedic Accessories; End use - Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027”

About Us

 Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

 Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

 For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

 Contact

Nikhil Sawlani Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: 1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog:  https://tmrblog.com Email: sales@transparencymarketresearch.com

[healthcare-domain]

Future | Growth and Emerging Trends in Medical Ceramics Market

Medical implants are artificial devices that are used to replace damaged or missing biological parts. Implants help deliver medication, monitor body functions, and provide support to organs and tissues in different applications (such as dental, orthopedic, and cardiovascular). The medical implants market is driven by the growing healthcare needs of the senior population, advancements in medical technologies, and the rising incidence of chronic diseases, such as osteoarthritis, cardiovascular diseases, neuropathic diseases, and congenital disorders, among others.

In 2015, there were 901 million elderly individuals (aged 60 years and above) globally, and this figure is projected to grow by 56% to reach 1.4 billion by 2030 (Source: United Nations). Moreover, in the US, the population of individuals aged over 65 years is expected to double between 2005 and 2030 (Source: National Institute on Aging). Also, in Japan, 40% of the population is expected to be over 65 years by 2060 (WHO).

The significant growth in the geriatric population is expected to result in an increased demand for joint reconstruction, cardiovascular surgeries, and dental replacement procedures and an increase in the prevalence of hearing loss. These factors are, in turn, expected to support the growth of the hearing, orthopedic, and dental implants market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237425129

Medical ceramics are key components in the manufacturing of various implantable devices, such as orthopedic implants (artificial hips, knee, shoulder, wrists, fracture fixation, and bone grafts), cardiovascular implants (heart valves, pacemakers, catheters, grafts, and stents), dental implants (enamels, fillings, prosthetics, and orthodontics), and hearing implants (cochlear implants). Considering the growing demand for implantable devices in different segments (such as cardiovascular, dental, and orthopedics), the uptake of medical ceramics is expected to increase in the coming years.

The development of medical ceramic products involves time-consuming processes and expensive clinical trials. These products have to be implanted inside the human body; they need to be biocompatible and comply with the ISO biocompatibility testing standards. However, it is difficult to anticipate the biocompatibility till the later stages of clinical trials, making companies and investors apprehensive of investing in this market.

The healthcare industry in emerging markets is growing rapidly, thus providing growth opportunities for medical ceramics manufacturers. Brazil, Russia, India, China, and South Africa (BRICS) are among the world's fastest-growing economies. The World Economic Forum estimates these emerging economies to account for around one-third of the global healthcare expenditure by 2020. The rising geriatric population in these countries will lead to increased demand for medical facilities and devices, which is likely to propel the growth of the medical ceramics market.

The medical ceramics market in Asia Pacific, particularly in China, Japan, and India, is expected to witness high growth in the coming five years. The medical ceramics market in the APAC is estimated to grow rapidly during the forecast period, considering the development of the region's healthcare sector. The major consumers of medical ceramics in the APAC are China, South Korea, and Japan.

Based on the type of material, the global medical ceramics market is segmented into bioinert ceramics, bioactive ceramics, bioresorbable ceramics, and piezoceramics. In 2019, the bioinert ceramics segment accounted for the largest share of the global medical ceramics market. Bioinert ceramics exhibit high fracture toughness, low thermal conductivity, excellent resistance to wear & corrosion, and extremely high bending & tensile strength. Bioinert ceramics are widely used in the orthopedic & dental industry.

[industryinsights]

Hip Implants Market Share, Size, Opportunities, Trends, Growth Factors, Revenue Analysis Till 2027

According to MRFR analysis, Hip Implants Market Share is expected to register a CAGR of 4.1% during the forecast period and is expected to reach USD 9,300 Million by 2025.

Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, which is also known as hip prosthesis. Hip replacement surgery can be performed as a hemi (half) replacement or total replacement. The growth of the global hip implants market is driven by various factors, such as the introduction of custom-made implants and the growing geriatric population. Increased product launches, mergers, acquisitions, and partnerships of the major players of the market attributed to the growth of the market. However, stringent government regulations on all-metal hip implants and an increase in the number of product recalls are projected to hamper the growth of the global hip implants market.

Several market players currently dominate the global hip implants market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For example, in May 2018, DePuy Synthes acquired Medical Enterprises Distribution, LLC, with its automated surgical impactor for hip replacement. Through this acquisition, the former developed and broadened the surgical impactor technology for a wide range of orthopedic surgery procedures.

Segmentation

The global hip implants market has been segmented based on the product, material, and end user.

The market, based on product, has been divided into total hip replacement implants and partial hip replacement implants. Total hip replacement segment is further segmented into fixed-bearing hip implants and mobile-bearing total hip implants. The partial hip implants segment has been further bifurcated into hip resurfacing implants and revision hip replacement implants.

The total hip replacement implants segment is likely to be the largest during the review period due to the increasing geriatric population and prevalence of hip-related disorders. The partial hip replacement implants devices segment is predicted to be the fastest-growing due to less deterioration and friction than all-metal hip implants.

Many players have introduced in the total hip replacement market with advanced technologies. For instance, in March 2019, DJO launched ADAPTABLE, a sterile surgeon-controlled leg and retractor holder, which is designed for the direct anterior approach for total hip arthroplasty.

The global hip implants market has been segregated, based on material, into metal-on-polyethylene, metal-on-metal, ceramic-on-metal, ceramic-on-polyethylene, and ceramic-on-ceramic.

The metal-on-polyethylene segment is expected to account for the largest share of the market attributing to the rising demand of polymer as it reduces the side-effects in comparison to regular hip implants. The ceramic-on-metal segment is touted to grow at an exponential rate due to less friction and deterioration than the metal hip implants.

The end users in the market are hospitals, orthopedic clinics, ambulatory surgical centers, and others.

The hospitals segment accounts for the largest share of the market as the availability of various facilities and treatment options in the hospitals. The orthopedic clinics segment is touted to grow at an exponential rate due to the presence of availability of skilled surgeons and well-developed infrastructure.

Key Players

Some of the key players in the global hip implants market are Corin (UK), DJO Global, Inc. (US), OMNILife science, Inc. (US), MicroPort Scientific Corporation (China), Stryker Corporation (UK), Zimmer Biomet Holdings, Inc. (US), Smith & Nephew PLC (UK), Exactech, Inc. (US), B. Braun Melsungen AG (Germany), and Aesculap Implant Systems, LLC (US).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The hip implants market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. The European hip implants market has been categorized as Western Europe and Eastern Europe. The Western European market has been further classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hip implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the growing geriatric population and increasing demand for hip replacement surgeries, the market in Asia-Pacific is expected to be the fastest-growing.

The hip implants market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[mrfrblogresearch02]

Bio implants Market size, Business Prospect, Industry Demand, Regional Trend and  by Forecast to 2027

Bioimplants or bio-implants are devices which are easily compatible with living tissues or organs within the body. The aging population and pressure to develop biocompatible implants with a long shelflife has brought evaluation of efficient and performance under question. The global bioimplants market report by Market Research Future (MRFR) covers developments of biomaterials, progress in manufacturing processes, and its scope for the period.

Market Scope:

The global bioimplants market Size can register 8.6% CAGR during the forecast period. It was valued at USD 98,350 million in 2017. Primary factors fueling market growth are bone degeneration cases among the elderly, prevalence of lifestyle diseases such as diabetes, infections, and others, and minimally invasive surgeries. Rise in research and development activities and developments such as 3D printing, laser technology, and nanotechnology can support market growth. Complex geometrical shapes of bones and tailored requirements by patients designed for rehabilitation and plastic surgeries can bode well for the market.

But unfavorable reimbursement policies, high prices of implants, and lack of skilled personnel in handling surgeries can hamper the growth of the global bioimplants market.

Market Regional Analysis:

Geographically, the global bioimplants market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas are deemed to dominate the global market owing to prevalence of chronic disorders such as diabetes and obesity, incidence of chronic diseases, a large geriatric pool, and increasing number of surgeries. According to the Centers for Disease Control & Prevention (CDC), nearly 93 million Americans suffered from obesity. Large number of hip and knee replacement surgeries is evidence of the large potential of the market.

Europe is the second-largest region of the market due to rise in research and development activities, occurrence of orthopedic disorders, and ample funding for the healthcare sector. The large number of cardiovascular disorder cases is giving prime impetus to the regional bioimplants market growth. According to the European Heart Network, more than 85 million patients were diagnosed with some form of cardiovascular disease in Europe in 2015.

APAC can display an exemplary growth rate during the forecast period owing to rising investments in healthcare, rise of disposable income levels, and a large geriatric population. According to the United Nations ESCAP, the population of patients aged 60 and above can reach 1.3 billion by 2050. Alarming number of road accidents are likely to spur the demand for bioimplants. This is supported by a report by Tokyo’s Keio University stating the number of patients with spinal cord injuries to reach 100,000 in 2019.

The MEA can register the lowest growth of the global bioimplants market due to lack of proper healthcare infrastructure, paucity of technical knowledge, and an underdeveloped healthcare sector.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6896

Market Segmentation:

The global bioimplants market has been segmented on the basis of type, material, origin and end-user.

The market on the basis of type has been classified as cardiovascular implant, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants and others. The cardiovascular implant segment has been further divided into stents, pacing devices and others. Dental implants are classified into plate form dental implant and root form dental implants. The spinal bioimplants segment has been further divided into form dental implant, intervertebral spacers, cervical implants, and motion preservation implants. Orthopedic Implants are divided into Orth biologics, trauma implants, joint replacement implants, and knee replacement implants. The ophthalmic implants segmented has been classified into glaucoma implants, and intraocular implants.

On the basis of material, the market has been divided into biomaterial metals, ceramics, alloys, and others. biomaterial metals are separated into titanium, gold, silver and platinum.

The market, by origin, has been segmented into autograft, allograft, xenograft, and synthetic.

On basis of end-user, the market has been divided into hospitals, clinics, specialty centers, and others.

Key Players:

Some of the key players in the global bioimplants market are C.R.Bard, Inc. ,Abbott,Boston Scientific Corporation,Dentsply Sirona,Invibio Ltd.,Integra LifeSciences,Johnson & Johnson Services, Inc.,Medtronic,Smith & Nephew plc,Stryker,Wright Medical Group N.V.,Cook Group, and Zimmer Biomet.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/bioimplants-market-6896

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[healthcare-market]

Orthopedic Biomaterials Market Research Insights Shared in Detailed Report

Orthopedic Biomaterials Market: Introduction

According to the report, the global orthopedic biomaterials market was valued at US$ 11.3 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Rise in percentage of population requiring orthopedic implants, and increase in incidence rate of injuries related to accidents, sports, and adventure are anticipated to augment the global orthopedic biomaterials market from 2019 to 2027. North America and Western Europe are expected to account for significant shares of the global orthopedic biomaterials market. The U.S. is likely to continue its dominance in the orthopedic biomaterials market during the forecast period. The country is likely to witness changes in reimbursement policies in the near future, aimed at increasing the quality of patient care.

According to the Centers for Disease Control and Prevention, in the U.S., annually 54.4 million adults are diagnosed with arthritis. Asia Pacific is projected to be a highly lucrative market for orthopedic biomaterials in the next few years. However, high competition is anticipated to restrain the global orthopedic biomaterials market.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1725

Rise in Percentage of Population Requiring Orthopedic Devices

The population more prone to orthopedic diseases primarily includes obese and geriatric populations. Cartilages become prone to strain and fatigue due to less water content as age progresses. This leads to arthritis and other complications, which require knee replacement procedures. Furthermore, other connective tissues such as ligaments attached to the bones become less flexible and more constrained. These factors are expected to drive the demand for orthopedic devices among the geriatric population. Prevalence of osteoarthritis, rheumatoid arthritis, fibromyalgia, juvenile arthritis, and other forms of orthopedic disorders is increasing primarily due to aging population, obesity, and changes in lifestyle.

Request a Sample of Orthopedic Biomaterials Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1725

Increase in Incidence Rate of Injuries Related to Accidents, Sports, and Adventure

Incidence of accidental injuries during sports, driving, and adventure has increased drastically in the last decade. A study carried out by the American Academy of Orthopedic Surgeons (AAOS) revealed that around 25% of sports injuries were related to lower extremities such as ankle and foot. Serious bone injuries have been reported recently among professionals as well as amateur sportspersons. Over 340,000 hip implant procedures are performed in the U.S. each year, which includes a number of patients aged between 40 and 50 who are focused toward maintaining a healthy lifestyle.

Request for Analysis of COVID19 Impact on Orthopedic Biomaterials Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1725

Product Recalls Affecting Adoption Rates to Restrain Market

Incidences of product recalls due to device inefficiency or manufacturing errors affect the adoption rate of these devices among surgeons and patients, thereby affecting revenue of the manufacturers. The global orthopedic biomaterials market has seen various product recalls in the past few years. In April 2017, Zimmer Biomet Holdings, Inc. recalled its class I devices SpF PLUS-Mini and SpF XL IIb implantable spinal fusion stimulators due to potential release of cytotoxic chemical higher than allowed levels. The company also recalled its Comprehensive Reverse Shoulder in June 2016, owing to high fracture rate.

Enquiry before Buying Orthopedic Biomaterials Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1725

Asia Pacific Orthopedic Biomaterials Market to Expand Significantly

Large population base, rise in incidence of orthopedic diseases, and improving economy in China, India, and others countries in Southeast Asia resulting in high per capita health care expenditure, are anticipated to drive the orthopedic biomaterials market in the region. The market is this region is highly price sensitive and Government cap, such as in India, controls most of the prices for orthopedic implants and other devices. The orthopedic biomaterials market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027.

Competition Landscape in Orthopedic Biomaterials Market

The report also provides profiles of leading players operating in the global orthopedic biomaterials market. These include Zimmer Biomet Holdings, Inc., Stryker, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Medtronic, DJO Global, Inc., Arthrex, Inc., NuVasive, Inc., and Globus Medical, Inc.

More Trending Reports by Transparency Market Research:

Telemedicine Market Telemedicine has evolved gradually with the rise of the Internet age. The ubiquity of smart devices that feature high-quality video transmission has opened up the possibilities of delivering remote healthcare to patients at their convenient locations. Thus, telemedicine is emerging as an alternative for in-person visits for primary as well as specialty care.

Life Sciences BPO Market In the life sciences BPO market, blockchain and serialization technologies are facing the challenges of counterfeit pharmaceuticals. In addition to providing a clearer and better perspective of clinical findings, virtual trials and data management are speeding up the decision making process. Investments in personalized medications and specialist therapies are gaining popularity.

Unfractionated Heparin Market Due to its numerous benefits, unfractionated heparin is gaining popularity. It is generally recognized due to its reversibility (protamine), short half-life, immediate beginning of action, and simple laboratory monitoring. Moreover, it is cost-effective. Unfractionated heparin is also used in the treatment of VTE, such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[blueweave8]

Ultra-High Molecular Weight Polyethylene Fiber Market Report 2022-2027

The global Ultra-High Molecular Weight Polyethylene Fiber market is growing at a potential growth rate Year-over-Year (YoY) and has reached USD 7.3 billion in 2019. The market is further expected to touch USD 15.0 billion by 2026, growing at a CAGR of 11.8% during 2020-2026 (forecast period). The Ultra-High Molecular Weight Polyethylene Fiber market is likely to grow in the forecast timeframe due to a rise in demand for ultra-fiber molecular weight polyethylene fibers from the aerospace & defense industry and in orthopedic implants. Additionally, it has excellent mechanical properties which include high abrasion resistance, high impact strength, and low coefficient of friction.

Growth Drivers

Increasing demand for orthopedics implants

The rising demand for orthopedics implants is the major driver for the market. The demand for orthopedic implants has risen significantly, due to the rise geriatric population that increases the risk of osteoporosis, osteoarthritis, technological innovations in orthopedic implants, and other musculoskeletal disorders. The ultra-high molecular weight polyethylene has been used in the implants in large amounts j making of prosthetics and thus it would benefit the market. It is used for non-absorbable sutures as it is strong and durable. Additionally, the sutures made using ultra-high molecular weight polyethylene are flatter than the conventionally used polyester and poly-blend sutures.

Excellent Properties of ultra-high molecular weight polyethylene

Ultra-high-molecular-weight polyethylene provides a combination of exceptional properties. This ultra-high-molecular-weight polyethylene thermoplastic material is tough with superior impact strength. It is often considered a corrosion-resistant material and exhibits virtually no water absorption. It is wear-resistant, non-sticking, and self-lubricating. Additionally, it provides the fracture's toughness, has a low friction coefficient, high impact strength, and low density. These properties have a popular choice as the articulating surfaces of joint replacements, such as hip, knee, ankle, and shoulder. Thus, these properties are driving the market growth.

Sample copy: https://www.blueweaveconsulting.com/report/global-ultra-high-molecular-weight-polyethylene-fiber-market-bwc20222/report-sample

Restraints

Presence of Substitutes in the market

The ultra-high-molecular-weight polyethylene market can face the major restraint that is the presence of other substitutes or alternative substitutes such as polyoxymethylene, urethane, fluoropolymers, and polycarbonate. Additionally, the volatility in raw material prices is likely to hamper the market growth during the review period. these alternatives are most used in a liquid form as a coating, adhesive, or sealant. It is also typically used in pesticides and fungicides. It can also be purchased at lower rates and some are easily available. Thus, the whole market can get impacted by this.

Impact of COVID-19 in industry

The global economy and humanity have been pushed into a crisis due to the COVID-19 pandemic. Due to the high infection rate and adverse impact on public health systems, various governments have enforced nationwide lockdowns significantly impacting manufacturing supply chains, trade, and related services. Players are currently considering digital solutions that would enable them to serve the community and provide new opportunities to do business. The production, manufacturing, supply chain, and other operations, have slowed down globally aimed to limit the spread of coronavirus,

The global impact of the coronavirus disease 2019 (COVID-19) is likely only beginning and would significantly affect the Ultra-High Molecular Weight Polyethylene Fiber market in 2020. The outbreak of COVID-19 has brought with it travel bans and quarantines; massive slowing of the supply chain; uncertainty in the stock market; falling business confidence, and growing panic among the population. Despite the growing uncertainty and panic, technology suppliers must continue to focus on their long-term investments, maintain engagement with partners and prospects, and look to specific markets for stability.

Ultra-High Molecular Weight Polyethylene Fiber Market: By Form

Based on the form, the Ultra-High Molecular Weight Polyethylene Fiber market is segmented into, sheets, rods & tubes, fibers, films, tapes, and others. The sheet segment is likely to dominate in the market mainly due to the extensive use of ultra-high molecular weight polyethylene sheets in the mechanical equipment industry. The sheet segment is also growing due to rising demand from the healthcare & medical end-use industry. The demand for sheets is also high in food production units, wherein the large volumes of containers namely can, and bottles need to be guided along conveyors these sheets are used in marine applications as they have low moisture absorption. Ultra-high molecular weight polyethylene is used in cryogenic components, due to its low operating temperature abilities.

Recent Development

·       In July 2019, DSM company has acquired the majority shares of ICD, an ultra-high molecular weight polyethylene fiber manufacturer in China. This acquisition of the majority share in ICD would be bringing the complementary manufacturing and technology assets to DSM and likely to strengthen the company’s presence in this ultra-high molecular weight polyethylene market.

·     In July 2019, DSM has also introduced Dyneema Purity Black fiber, which is the first black medical-grade ultra-high molecular weight polyethylene fiber. The fiber builds are expected to be 15 times stronger than steel, have a small profile, high pliability, and biocompatibility.

Competitive landscape

The Ultra-High molecular weight polyethylene fiber market is fragmented owing to the presence of a number of companies that provide varied Ultra-High Molecular Weight Polyethylene Fiber products. However, the companies that hold the majority share of the Ultra-High Molecular Weight Polyethylene Fiber market are Celanese Corporation, Koninklijke DSM N.V.,, LyondellBasell Industries N.V., Braskem S.A, Asahi Kasei Corporation, Du Pont De Nemours Inc., Saudi Arabia Basic Industries Corporation, Mitsui Chemicals, Inc., Honeywell International, Inc. Celanese Corporation and Teijin Limited, s), Nanoshell LLC and other prominent players.

About Us

BlueWeave Consulting (BWC) provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt. Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com

[jesse-pinkman123]

Total Knee Arthroplasty Market To Surpass US$ 11,484.8 Million By 2028

Total knee arthroplasty is one of the most common surgery procedure performed for management of pain and restoring function of severely damaged knee joint in orthopedic conditions such as osteoarthritis. This surgery involves cutting away damaged portions of the knee bones and replacing them with metal alloy implants and polyethylene polymers. Orthopedic surgeons carry out a full medical evaluation to determine suitability and risks associated with the surgery. Imaging analysis of the knee such as radiography is carried out to assess the severity of joint damage and ensure proper alignment of the artificial joint before closing the surgical incision. Total knee arthroplasty is recommended in conditions such as severe knee pain, while carrying out normal day to day activities, knee deformity, chronic knee inflammation, and failure of other drug or surgery treatments for pain management.

Global Total Knee Arthroplasty Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020.

For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 177,866,160 cases and 3,857,974 deaths due to coronavirus disease (COVID-19) were reported till June 20, 2021, across the globe.

Request Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/4635

Impact of COVID-19 on Demand and Supply of Total Knee Arthroplasty

The COVID-19 pandemic and lockdown in various countries across the globe have negatively impacted the financial status of businesses across all sectors. The medical devices sector is one such sector which has been majorly impacted by the pandemic.

During the COVID-19 pandemic, several patients with arthritis are struggling to receive treatment due to hospitals canceling or delaying surgeries and other procedures, including arthroplasty and other knee replacement surgeries. There is also a concern that patients who have mild arthritis that require timely implementation of surgery have unfortunately concluded that the risk of contracting COVID-19 may outweigh the benefits of arthroplasty. As non-essential surgery restrictions remain in parts of the U.S., the COVID-19 pandemic is having a profound impact on hip and knee arthroplasty surgery volume and could translate to major financial loss.

For instance, a study named ‘The Initial Impact of COVID-19 on Total Hip and Knee Arthroplasty,’ was published in the Elsevier Public Health Emergency Collection, in January 2021, which conducted a retrospective analysis of Medicare fee-for-service beneficiaries undergoing primary and revision total knee arthroplasty (TKA) and total hip arthroplasty (THA) in U.S. from January 1, 2020 to March 31, 2020, reported a steep decline of 94% in total knee arthroplasty (TKA) volumes during mid-March of 2020 and the total daily hospital medicare revenue for arthroplasty declined by 87% and surgeon revenue decreased by 85%.

Thus, impact of the coronavirus (COVID-19) pandemic is expected to limit the growth of the global total knee arthroplasty market during the forecast period, owing to halt and delay of total knee arthroplasty surgeries during the pandemic.

The global total knee arthroplasty market is estimated to be valued at US$ 8,739.2 Mn in 2021, and is expected to exhibit a CAGR of 4.0% over the forecast period (2021-2028).

Buy Now this Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4635

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

[adnanmaximize]

Hip implants are a medical device that is used to restore mobility and relieve pain associated with arthritis and other hip disorders or accidents. Every hip implant has benefits and drawbacks. Device design elements such as size, shape, material, and measurements vary for each hip implant system.

[nitasonwane]

Orthopedic Devices Market Growth, Size, Demand, Trends, Insights and Forecast 2027

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Joint Reconstruction Segment to Lead Backed by Increasing Number of Surgical Procedures

Based on type, the market is grouped into joint reconstruction devices, dental implants, trauma devices, spinal devices, orthobiologic devices, arthroscopy devices, trauma devices, and others. Out of these, in 2018, the joint reconstruction segment held 35.8% in terms of orthopedic devices market share and is anticipated to lead the market throughout the forecast period. This growth is attributable to the rising number of procedures, namely, extrementies and shoulder reconstructions, hip and knee replacements, and other similar procedures associated with joints. The arthroscopy devices segment is likely to expand at fast pace owing to the increasing emergence of novel products and upsurging cases of soft tissue injuries related to sports.

Regional Analysis-

High Purchasing Power of the Masses to Favor Growth in Asia Pacific

Geographically, the market is fragmented into Latin America, Asia Pacific, the Middle East and Africa, North America, and Europe. Amongst these, North America procured USD 23.86 billion orthopedic medical devices market revenue in 2018. This growth is attributable to the presence of adequate reimbursement policies, as well as surging incidence of orthopedic surgeries. Apart from these, availability of state-of-the-art treatment options and rising awareness among the patient pool regarding the presence of these advanced devices would contribute to the market growth.

Europe, on the other hand, is set to generate the second-largest market share in the coming years on account of the rising healthcare expenditure and increasing awareness campaigns about unique products. Asia Pacific would showcase a considerable CAGR because of the growing patient pool and increasing purchasing power of the masses in the developing nations, such as China and India.